ArticleBioinformation2026
Role of endocervical curettage during colposcopy for women with abnormal cervical screening results in predicting cervical intraepithelial neoplasia.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The problem of accurately predicting high-grade cervical intraepithelial neoplasia (CIN2+) in women with positive screening tests remains a challenge in clinical practice. Therefore, it is of interest to evaluate the role of endocervical curettage (ECC) in predicting high-grade cervical intraepithelial neoplasia (CIN2+) in women with positive screening tests. Conducted at Bangabandhu Sheikh Mujib Medical University, the study included 112 women aged 30-60 with abnormal Pap smears or VIA-positive results. While colposcopy-directed biopsy (CDB) detected 23.2% of CIN2+ cases, ECC in combination with CDB identified 35.7%. Data shows that ECC to enhance detection but with lower sensitivity (38.5%) and positive predictive value (41.7%) compared to biopsy alone. ECC proved beneficial in improving CIN2+ detection in high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.